Brief: China Pharma Had Cash And Cash Equivalents of $1.1 mln As Of Dec 31, 2019
14/04/2020 21:53
April 14 (Reuters) - China Pharma Holdings Inc CPHI.A :
* CHINA PHARMA - AUDIT OPINION BY CO'S ACCOUNTING FIRM
RELATED TO
STATEMENTS FOR YEAR ENDED DEC. 31, 2019 INCLUDED A GOING CONCERN
EXPLANATORY PARAGRAPH
* CHINA PHARMA HOLDINGS INC - AS OF DECEMBER 31, 2019
COMPANY HAD
CASH AND CASH EQUIVALENTS OF $1.1 MILLION COMPARED TO $1.2
MILLION AS OF DECEMBER 31, 2018
Source text for Eikon: ID:nPn2c6yQpa
Further company coverage: CPHI.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Pharma Holdings
See all newsBrief: China Pharma - Not Aware Of Any Material Corporate Developments Explaining Recent Market Activity
Brief: China Pharma Says Co Knows Of No Events That Could Have Caused Unusual Market Activity
Brief: China Pharma Holdings Inc - NYSE American Contacts China Pharma Regarding Unusual Market Activity On May 12 And 13
Brief: China Pharma Holdings Files For Non-Timely 10-K With US SEC
Brief: China Pharma Holdings Inc. Announces 1-For-10 Reverse Stock Split